Clinical impact of early response to first‐line VEGFR‐TKI in patients with metastatic renal cell carcinoma on survival: A multi‐institutional retrospective study

It remains unknown whether the early response to vascular endothelial growth factor receptor tyrosine kinase inhibitor (VEGFR‐TKI) management in malignancies links to long‐term survival. The objective of this study was to investigate the survival rates and predictive factors of early response in pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Sobu, Ryuta, Numakura, Kazuyuki, Naito, Sei, Hatakeyama, Shingo, Kato, Renpei, Koguchi, Tomoyuki, Kojima, Takahiro, Kawasaki, Yoshihide, Kandori, Syuya, Kawamura, Sadafumi, Arai, Yoichi, Ito, Akihiro, Nishiyama, Hiroyuki, Kojima, Yoshiyuki, Obara, Wataru, Ohyama, Chikara, Tsuchiya, Norihiko, Habuchi, Tomonori
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
RESEARCH ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9972009/
https://www.ncbi.nlm.nih.gov/pubmed/36200612
http://dx.doi.org/10.1002/cam4.5268

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9972009/
https://www.ncbi.nlm.nih.gov/pubmed/36200612
http://dx.doi.org/10.1002/cam4.5268

Ejemplares similares